share_log
Reuters ·  Apr 29 09:00
Merck & Co Inc: V116 Elicited Immune Responses That Were Noninferior Compared to Ppsv23 for 12 Serotypes (or Strains) Common to Both Vaccines
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment